Erratum to clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation
Ann Palliat Med
.
2020 Jan;9(1):120.
doi: 10.21037/apm.2019.12.08.
Authors
Xueyang Hu
1
,
Wenjun Chen
2
,
Xiaoqiu Li
1
,
Chenchen Zhao
1
,
Congjun Zhang
1
,
Fuxing Xiong
1
,
Hongyang Wu
3
Affiliations
1
Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China.
2
Phase I Clinical Center, Anhui Chest Hospital, Hefei 230022, China.
3
Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, China. wuhoya1970@163.com.
PMID:
32005071
DOI:
10.21037/apm.2019.12.08
No abstract available
Publication types
Published Erratum